Medidata Selected by ASLAN Pharmaceuticals
Medidata announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals
Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company. ASLAN’s will be using the Medidata Clinical Cloud™ to support the company’s strategy of maximizing the value of its in-licensed drug portfolio by conducting clinical development in Asia.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025